Amgen is actively filling in the gaps and addressing ongoing questions related to its gastric cancer drug, aiming to clarify the drug’s potential and development progress.
Back
Amgen is actively filling in the gaps and addressing ongoing questions related to its gastric cancer drug, aiming to clarify the drug’s potential and development progress.